Cellectis (CLLS) Tops Q4 EPS by 19c

Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.54), $0.19 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.08 million versus the consensus estimate of $4.95 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Hertz Global (HTZ) PT Lowered to $3.50 at Morgan Stanley
• SanDisk (SNDK) PT Raised to $3,000 at Bernstein SocGen Group, 'We believe this is not understood by the Street'